Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 1.000 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.648 | |
| 2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.644 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.642 | |
| 2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.628 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.627 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.618 | |
| 2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.609 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.603 | |
| 2ycf | YCF | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.569 | |
| 4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.562 | |
| 4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.549 | |
| 4bdd | Z0O | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.531 | |
| 4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.519 | |
| 1jkl | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.504 | |
| 4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.495 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.483 | |
| 2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.482 | |
| 4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.482 | |
| 2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
| 4bdi | HAU | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.479 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.468 | |
| 4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
| 4wsq | KSA | AP2-associated protein kinase 1 | 2.7.11.1 | 0.464 | |
| 1ig1 | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.462 | |
| 3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.461 | |
| 3lij | ANP | Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands | / | 0.461 | |
| 2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
| 3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.459 | |
| 4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.459 | |
| 2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.458 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.457 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.457 | |
| 5av3 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.457 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.456 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.455 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.454 | |
| 3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.454 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
| 2yaa | ATP | Death-associated protein kinase 2 | / | 0.452 | |
| 3bqr | 4RB | Death-associated protein kinase 3 | / | 0.452 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.452 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
| 4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.451 | |
| 2y7j | B49 | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 2.7.11.19 | 0.450 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.449 | |
| 4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.449 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.449 | |
| 1jkk | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.448 | |
| 2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.448 | |
| 3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
| 2w4j | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.447 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 3qd4 | 3Q6 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.446 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.444 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.443 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
| 2vgp | AD6 | Aurora kinase B-A | 2.7.11.1 | 0.440 |